A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions

NCT01646294 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics of YM178
Healthy Subjects

Interventions

DRUG: YM178 modified release (OCAS)
DRUG: YM178 immediate release (IR)

Sponsor

Astellas Pharma Europe B.V.